化学
异构化
动力学分辨率
组合化学
定向进化
苯乙烯氧化物
蛋白质工程
异构酶
催化作用
生物转化
苯乙烯
酶
对映选择合成
有机化学
生物化学
共聚物
突变体
聚合物
基因
作者
Joel P. S. Choo,Fernanda L. Sirota,Willy W. L. See,Birgit Eisenhaber,Zhi Li
出处
期刊:ACS Catalysis
[American Chemical Society]
日期:2023-08-11
卷期号:13 (17): 11268-11276
被引量:6
标识
DOI:10.1021/acscatal.3c02777
摘要
(S)-Arylpropionic acids are the pharmacologically active enantiomers of profen drugs that are challenging to synthesize chemically. Here, we report a chemoenzymatic synthesis of (S)-profens from alkenes involving styrene oxide isomerase (SOI)-catalyzed enantioretentive Meinwald-type isomerization of epoxides to aldehydes. This success relies on the engineering of SOI to accept larger substrates with enhanced activity for the rate-limiting isomerization step using a multi-Harmony analysis to guide directed evolution, which represents the first successful rational-based evolution of a membrane-associated enzyme without structural information. The engineered SOI-F35A/A131Y demonstrated 10.5-fold improvement in catalytic efficiency compared to wild-type SOI and was successfully combined in a cascade with aldehyde dehydrogenase to produce four (S)-profens from chemically derived (S)-epoxides in 83–89% yield and 90–94% ee. This work represents a simple and cleaner route to synthesize (S)-profens from alkenes, and the engineered SOI can be useful to produce other types of chiral molecules.
科研通智能强力驱动
Strongly Powered by AbleSci AI